Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Cardiff

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PETCecilie B Rygh, Shengping Qin, Jai W Seo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancerMarisa G Ponzo, Robert Lesurf, Stephanie Petkiewicz, et al.
Plos One|January 25, 2019
Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostateDong-Hong Lee, Eun-Jeong Yu, Joseph Aldahl, et al.
Breast Cancer Research : BCR|September 19, 2009
The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cellsHeather C Workman, Jamie K Miller, Ellen Q Ingalla, et al.
Molecular Carcinogenesis|August 28, 2015
The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor developmentCassandra J Adams, Jennifer S Yu, Jian-Hua Mao, et al.
Oncogene|July 31, 2019
Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostateYongfeng He, Daniel T Johnson, Julie S Yang, et al.
Nature|October 12, 2004
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerCatherine M Shachaf, Andrew M Kopelman, Constadina Arvanitis, et al.
Cancer Research|January 28, 2012
Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumorsKatherine D Watson, Chun-Yen Lai, Shengping Qin, et al.
Cancer Cell|November 14, 2006
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisPatrick W B Derksen, Xiaoling Liu, Francis Saridin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
The Snf1-related kinase, Hunk, is essential for mammary tumor metastasisGerald B W Wertheim, Thomas W Yang, Tien-chi Pan, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PETCecilie B Rygh, Shengping Qin, Jai W Seo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancerMarisa G Ponzo, Robert Lesurf, Stephanie Petkiewicz, et al.
Plos One|January 25, 2019
Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostateDong-Hong Lee, Eun-Jeong Yu, Joseph Aldahl, et al.
Breast Cancer Research : BCR|September 19, 2009
The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cellsHeather C Workman, Jamie K Miller, Ellen Q Ingalla, et al.
Molecular Carcinogenesis|August 28, 2015
The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor developmentCassandra J Adams, Jennifer S Yu, Jian-Hua Mao, et al.
Oncogene|July 31, 2019
Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostateYongfeng He, Daniel T Johnson, Julie S Yang, et al.
Nature|October 12, 2004
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerCatherine M Shachaf, Andrew M Kopelman, Constadina Arvanitis, et al.
Cancer Research|January 28, 2012
Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumorsKatherine D Watson, Chun-Yen Lai, Shengping Qin, et al.
Cancer Cell|November 14, 2006
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisPatrick W B Derksen, Xiaoling Liu, Francis Saridin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
The Snf1-related kinase, Hunk, is essential for mammary tumor metastasisGerald B W Wertheim, Thomas W Yang, Tien-chi Pan, et al.
Pageof 19